Connor Clark & Lunn Investment Management Ltd. Buys 24,266 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Connor Clark & Lunn Investment Management Ltd. grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 28.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 109,162 shares of the company's stock after purchasing an additional 24,266 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.13% of HealthEquity worth $8,935,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. International Assets Investment Management LLC purchased a new stake in HealthEquity during the 2nd quarter valued at about $35,000. Paladin Wealth LLC purchased a new stake in shares of HealthEquity during the third quarter valued at approximately $39,000. GAMMA Investing LLC grew its holdings in shares of HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after purchasing an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity in the second quarter worth $73,000. Finally, 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the 3rd quarter valued at $112,000. Institutional investors own 99.55% of the company's stock.

Insider Activity

In other news, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock worth $884,517 over the last 90 days. 2.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and set a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. The Goldman Sachs Group assumed coverage on HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price for the company. Barrington Research restated an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Finally, BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $107.23.

HealthEquity Stock Down 0.4 %

Shares of HealthEquity stock traded down $0.40 during midday trading on Friday, hitting $104.25. The company had a trading volume of 578,193 shares, compared to its average volume of 625,683. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.68. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The stock has a market capitalization of $9.10 billion, a P/E ratio of 86.36, a P/E/G ratio of 1.61 and a beta of 0.52. The company has a 50 day moving average of $87.22 and a 200 day moving average of $81.73.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, equities analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.